Role Of S-Nitrosylation In The Extrinsic Apoptotic Signalling Pathway In Cancer

Stéphanie Plenchette1

  • 1Laboratoire d'Immunologie et Immunothérapie des Cancers, EPHE-Université de Bourgogne EA 7269, Faculté de Médecine, Dijon, France.

Redox Biology
|February 7, 2017
PubMed

Insights

Tumor cells resist apoptosis, hindering cancer treatment. Nitric oxide (NO) modification, specifically S-nitrosylation, of death receptors like Fas can trigger apoptosis, offering a potential therapeutic strategy for tumor regression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Tumor cells often develop resistance to apoptosis, a programmed cell death mechanism, posing a significant challenge for cancer therapy.
  • Activating death receptor signaling pathways is a key strategy to overcome apoptotic resistance and induce tumor regression.
  • Tumor Necrosis Factor (TNF)-family death receptor ligands, such as TRAIL, FasL, and TNF-α, play crucial roles in initiating cell death signaling.

Purpose of the Study:

  • To investigate the role of post-translational modifications, particularly S-nitrosylation, in regulating TNF-family death receptor signaling pathways.
  • To explore how nitric oxide (NO) influences cell fate decisions in tumor cells exposed to death receptor ligands.
  • To elucidate the molecular mechanisms by which S-nitrosylation of death receptors promotes apoptosis and tumor regression.

Main Methods:

  • Examining the S-nitrosylation of death receptors (DR4 and Fas) following treatment with NO donors or glyceryl trinitrate (GTN).
  • Analyzing the effect of S-nitrosylation on the redistribution of Fas to lipid rafts and the formation of the death-inducing signal complex (DISC).
  • Investigating the regulatory mechanisms of the TNF-α/TNFR1 signaling pathway by S-nitrosylation.

Main Results:

  • S-nitrosylation of death receptor DR4 promotes apoptosis upon treatment with an NO donor.
  • S-nitrosylation of Fas, induced by glyceryl trinitrate (GTN), facilitates its redistribution to lipid rafts and DISC formation, leading to apoptosis.
  • S-nitrosylation emerges as a critical post-translational modification controlling cell fate in TNF-family death receptor signaling.

Conclusions:

  • S-nitrosylation is a key regulatory mechanism in TNF-family death receptor signaling pathways.
  • Targeting S-nitrosylation of death receptors presents a promising therapeutic strategy to overcome apoptotic resistance in tumors.
  • Further research into NO-mediated regulation of TNF-α/TNFR1 signaling could uncover novel anti-cancer treatments.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K